Author

C.-S. Chen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:C. elegans· 1 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Cameron· 1 shared A. Gurakar· 1 shared A. M. Dauki· 1 shared A. R. Ahmadi· 1 shared B. Gao· 1 shared B. Peiffer· 1 shared B. Philosophe· 1 shared C. C. Coss· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Cameron

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Discovery and characterization of cross-reactive intrahepatic antibodies in severe alcoholic hepatitis

A. R. Ahmadi, G. Song, T. Gao, J. Ma, X. Han, M.-W. Hu, A. Cameron, R. N. Wesson, B. Philosophe, S. Ottmann, E. King, A. Gurakar, L. Qi, B. Peiffer, J. Burdick, , Z. Sun

This study identifies cross-reactive intrahepatic antibodies in severe alcoholic hepatitis that target both bacterial antigens and human proteins, suggesting a role in disease pathogenesis.

bioRxiv · Feb 23, 2023Pathology

Pathogenicity of urinary tract infection Escherichia coli in Caenorhabditis elegans

M. Hashimoto, Y.-F. Ma, S.-T. Wang, C.-S. Chen, C.-H. Teng

This study establishes a C. elegans model to screen UPEC strains and identifies iron acquisition genes as key to pathogenicity.

bioRxiv · Nov 28, 2019Microbiology

Overcoming Resistance to Anabolic Selective Androgen Receptor Modulator (SARM) Therapy in Experimental Cancer Cachexia with Histone Deacetylase Inhibitor AR-42

Y.-C. Tseng, S. G. Liva, A. M. Dauki, M. Sovic, S. E. Henderson, Y.-C. Kuo, J. A. Benedict, S. K. Kulp, M. Campbell, T. Bekaii-Saab, M. A. Phelps, C.-S. Chen, C. C. Coss

This study combines a SARM and HDAC inhibitor to improve anti-cachectic efficacy in a mouse model of cancer cachexia, showing significant improvements in bodyweight and muscle mass.

bioRxiv · Oct 5, 2018 · PreprintCancer Biology